Drugmaker GlaxoSmithKline To Invest $216M In Factories, R&D In Africa

Reuters: Drugmaker GSK to invest $200 million in African factories, R&D
“Drugmaker GlaxoSmithKline plans to invest up to 130 million pounds ($216 million) in Africa over the next five years as chronic diseases become more common among the continent’s swelling urban middle classes…” (Hirschler, 3/31).